Performance evaluation of automated immunoassays on the Technicon Immuno I system

Clinical Chemistry

Volumn 42, Issue 10, 1996, Pages 1695-1701

  Letellier, Marc ^a   Lévesque, Ann ^a   Daigle, Francine ^a   Grant, Andrew ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

correlation; detection limits; enzyme immunoassay; precision; random access analyzer

Indexed keywords

ALPHA FETOPROTEIN; CARCINOEMBRYONIC ANTIGEN; FERRITIN; FOLLITROPIN; HYDROCORTISONE; LIOTHYRONINE; LUTEINIZING HORMONE; PROLACTIN; PROSTATE SPECIFIC ANTIGEN; THYROTROPIN;

ACCURACY; ANTIGEN BINDING; ARTICLE; AUTOMATION; BINDING SITE; ENZYME IMMUNOASSAY; LATEX AGGLUTINATION TEST;

EID: 0029854223     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.10.1695     Document Type: Article

References (16)

1. NCCLS tentative guideline EP5-T2. Evaluation of precision performance of clinical chemistry devices. Villanova, PA: National Committee for Clinical Laboratory Standards, 1992.
2. NCCLS proposed guideline EP6-P. Evaluation of the linearity of quantitative analytical methods. Villanova, PA: National Committee for Clinical Laboratory Standards, 1992.
3. Nicoloff JT, Spencer CA. Clinical reviews 12. The use and misuse of the sensitive thyrotropin assays. J Clin Endocrinol Metab 1990;71:553-8.
4. Spencer CA, Takeuchi M, Kazarosyan M, MacKenzie F, Beckett GJ, Wilkinson E. Interlaboratory/intermethod differences in functional sensitivity of immunometric assays of thyrotropin (TSH) and impact on reliability of measurement of subnormal concentrations of TSH. Clin Chem 1995;41:367-74.
5. 4 estimate or sensitive TSH measurement. J Clin Immunoassay 1989;12:82-9.
6. Hay ID, Bayer MF, Kaplan MM, Klee GG, Larsen PR, Spencer CA, et al. American Thyroid Association assessment of current free hormone and thyrotropin measurements and guidelines for future clinical assays. Clin Chem 1991;37:2002-6.
7. Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyrotropin (TSH) assays. Clin Chem 1996;42:140-5.
8. Browning MCK, McFarlane NP. Objective interpretation of results for tumour markers. J Nucl Med Allied Sci 1990:34(Suppl):89-91.
9. Ricos C, Arbos MA. Quality goals for hormone testing. Ann Clin Biochem 1990;27:353-8.
10. Gallacher SK, Johnson LK, Milne DB. Short-term and long-term variability of indices related to nutritional status. I: Ca, Cu, Fe, Mg, and Zn. Clin Chem 1989;35:369-73.
11. Browning MCK, Ford RP, Callaghan SJ, Fraser CG. Intra- and interindividual biological variation of five analytes used in assessing thyroid function: implications for necessary standards of performance and the interpretation of results. Clin Chem 1986; 32:962-6.
12. Fraser CG, Petersen PH. Desirable standards for laboratory tests if they are to fulfill medical needs. Clin Chem 1993;39:1447-55.
13. Ekins R. Measurement of free hormones in blood. Endocr Rev 1990;11:5-41.
14. Zhou Z, Ng PC, Belenky A, Allard WJ, Yeung KK. Technicon Immuno 1® PSA assay measures both free and complexed PSA forms on an equal molar basis [Abstract]. Clin Chem 1995;41: S223.
15. Tillyer CR, Konings M, Gobin PT, Iqbal J. Disagreement between the Roche Cobas Core and Hybritech Tandem E PSA assays when measuring free, complexed and total serum prostate specific antigen. Ann Clin Biochem 1994;31:501-5.
16. Bankson DD, Lyon ME, Costales LV, Haver VM. The response of assays for total prostate specific antigen to changing proportions of "free" and alpha-1-antichymotrypsin bound PSA [Abstract]. Clin Chem 1994;40:1009.